Table 1 Baseline characteristics of patients whose prescriptions were included in the study (n = 310)
n (%) | Mean (SD) | |
|---|---|---|
Male Sex | 149 (48.1) | |
Age | 66.2 (20.1) | |
Diagnosis | ||
Infections | 124 (39.9) | |
Neurological disorders | 40 (12.9) | |
Gastrointestinal diseases | 31 (10) | |
Electrolyte disturbances | 25 (8.1) | |
Cancer/Chemotherapy | 19 (6.1) | |
Respiratory diseases | 16 (5.2) | |
Cardiac diseases | 11 (3.5) | |
Others | 44 (14.3) | |
Contraindication for pharmacologic prophylaxis | 54 (17.4) | |
Contraindication for GCS or IPC | 5 (1.6) | |
Surgery | 38 (12.6) | |
Major RF | 103 (33.2) | |
Number of RF | 2.8 (1.1) | |
Risk Group | ||
A | 97 (31.1) | |
B | 86 (27.7) | |
C | 92 (29.7) | |
D | 6 (1.9) | |
E | 29 (9.4) |